COMPASS

A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's disease

Fan Zhu, Bharat Panwar, Hiroko H. Dodge, Hongdong Li, Benjamin M. Hampstead, Roger L. Albin, Henry L. Paulson, Yuanfang Guan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We present COMPASS, a COmputational Model to Predict the development of Alzheimer's diSease Spectrum, to model Alzheimer's disease (AD) progression. This was the best-performing method in recent crowdsourcing benchmark study, DREAM Alzheimer's Disease Big Data challenge to predict changes in Mini-Mental State Examination (MMSE) scores over 24-months using standardized data. In the present study, we conducted three additional analyses beyond the DREAM challenge question to improve the clinical contribution of our approach, including: (1) adding pre-validated baseline cognitive composite scores of ADNI-MEM and ADNI-EF, (2) identifying subjects with significant declines in MMSE scores, and (3) incorporating SNPs of top 10 genes connected to APOE identified from functional-relationship network. For (1) above, we significantly improved predictive accuracy, especially for the Mild Cognitive Impairment (MCI) group. For (2), we achieved an area under ROC of 0.814 in predicting significant MMSE decline: our model has 100% precision at 5% recall, and 91% accuracy at 10% recall. For (3), "genetic only" model has Pearson's correlation of 0.15 to predict progression in the MCI group. Even though addition of this limited genetic model to COMPASS did not improve prediction of progression of MCI group, the predictive ability of SNP information extended beyond well-known APOE allele.

Original languageEnglish (US)
Article number34567
JournalScientific Reports
Volume6
DOIs
StatePublished - Oct 5 2016

Fingerprint

Alzheimer Disease
Genetic Models
Single Nucleotide Polymorphism
Crowdsourcing
Peptide Elongation Factor 2
Benchmarking
Aptitude
Disease Progression
Alleles
Genes
Cognitive Dysfunction

ASJC Scopus subject areas

  • General

Cite this

COMPASS : A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's disease. / Zhu, Fan; Panwar, Bharat; Dodge, Hiroko H.; Li, Hongdong; Hampstead, Benjamin M.; Albin, Roger L.; Paulson, Henry L.; Guan, Yuanfang.

In: Scientific Reports, Vol. 6, 34567, 05.10.2016.

Research output: Contribution to journalArticle

Zhu, Fan ; Panwar, Bharat ; Dodge, Hiroko H. ; Li, Hongdong ; Hampstead, Benjamin M. ; Albin, Roger L. ; Paulson, Henry L. ; Guan, Yuanfang. / COMPASS : A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's disease. In: Scientific Reports. 2016 ; Vol. 6.
@article{d566260cb9814132b01efa78f1f67661,
title = "COMPASS: A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's disease",
abstract = "We present COMPASS, a COmputational Model to Predict the development of Alzheimer's diSease Spectrum, to model Alzheimer's disease (AD) progression. This was the best-performing method in recent crowdsourcing benchmark study, DREAM Alzheimer's Disease Big Data challenge to predict changes in Mini-Mental State Examination (MMSE) scores over 24-months using standardized data. In the present study, we conducted three additional analyses beyond the DREAM challenge question to improve the clinical contribution of our approach, including: (1) adding pre-validated baseline cognitive composite scores of ADNI-MEM and ADNI-EF, (2) identifying subjects with significant declines in MMSE scores, and (3) incorporating SNPs of top 10 genes connected to APOE identified from functional-relationship network. For (1) above, we significantly improved predictive accuracy, especially for the Mild Cognitive Impairment (MCI) group. For (2), we achieved an area under ROC of 0.814 in predicting significant MMSE decline: our model has 100{\%} precision at 5{\%} recall, and 91{\%} accuracy at 10{\%} recall. For (3), {"}genetic only{"} model has Pearson's correlation of 0.15 to predict progression in the MCI group. Even though addition of this limited genetic model to COMPASS did not improve prediction of progression of MCI group, the predictive ability of SNP information extended beyond well-known APOE allele.",
author = "Fan Zhu and Bharat Panwar and Dodge, {Hiroko H.} and Hongdong Li and Hampstead, {Benjamin M.} and Albin, {Roger L.} and Paulson, {Henry L.} and Yuanfang Guan",
year = "2016",
month = "10",
day = "5",
doi = "10.1038/srep34567",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - COMPASS

T2 - A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's disease

AU - Zhu, Fan

AU - Panwar, Bharat

AU - Dodge, Hiroko H.

AU - Li, Hongdong

AU - Hampstead, Benjamin M.

AU - Albin, Roger L.

AU - Paulson, Henry L.

AU - Guan, Yuanfang

PY - 2016/10/5

Y1 - 2016/10/5

N2 - We present COMPASS, a COmputational Model to Predict the development of Alzheimer's diSease Spectrum, to model Alzheimer's disease (AD) progression. This was the best-performing method in recent crowdsourcing benchmark study, DREAM Alzheimer's Disease Big Data challenge to predict changes in Mini-Mental State Examination (MMSE) scores over 24-months using standardized data. In the present study, we conducted three additional analyses beyond the DREAM challenge question to improve the clinical contribution of our approach, including: (1) adding pre-validated baseline cognitive composite scores of ADNI-MEM and ADNI-EF, (2) identifying subjects with significant declines in MMSE scores, and (3) incorporating SNPs of top 10 genes connected to APOE identified from functional-relationship network. For (1) above, we significantly improved predictive accuracy, especially for the Mild Cognitive Impairment (MCI) group. For (2), we achieved an area under ROC of 0.814 in predicting significant MMSE decline: our model has 100% precision at 5% recall, and 91% accuracy at 10% recall. For (3), "genetic only" model has Pearson's correlation of 0.15 to predict progression in the MCI group. Even though addition of this limited genetic model to COMPASS did not improve prediction of progression of MCI group, the predictive ability of SNP information extended beyond well-known APOE allele.

AB - We present COMPASS, a COmputational Model to Predict the development of Alzheimer's diSease Spectrum, to model Alzheimer's disease (AD) progression. This was the best-performing method in recent crowdsourcing benchmark study, DREAM Alzheimer's Disease Big Data challenge to predict changes in Mini-Mental State Examination (MMSE) scores over 24-months using standardized data. In the present study, we conducted three additional analyses beyond the DREAM challenge question to improve the clinical contribution of our approach, including: (1) adding pre-validated baseline cognitive composite scores of ADNI-MEM and ADNI-EF, (2) identifying subjects with significant declines in MMSE scores, and (3) incorporating SNPs of top 10 genes connected to APOE identified from functional-relationship network. For (1) above, we significantly improved predictive accuracy, especially for the Mild Cognitive Impairment (MCI) group. For (2), we achieved an area under ROC of 0.814 in predicting significant MMSE decline: our model has 100% precision at 5% recall, and 91% accuracy at 10% recall. For (3), "genetic only" model has Pearson's correlation of 0.15 to predict progression in the MCI group. Even though addition of this limited genetic model to COMPASS did not improve prediction of progression of MCI group, the predictive ability of SNP information extended beyond well-known APOE allele.

UR - http://www.scopus.com/inward/record.url?scp=84990181626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990181626&partnerID=8YFLogxK

U2 - 10.1038/srep34567

DO - 10.1038/srep34567

M3 - Article

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 34567

ER -